Tellgen is pleased to announce its participation in the China Association of Clinical Laboratory Practice Expo (CACLP) 2026, which will be held from March 21 to 23, 2026, at the Xiamen International Expo Center, Xiamen, China During the exhibition, Tellgen will present a comprehensive portfolio of advanced diagnostic solutions at Booth 3-1504. The showcased technologies …

Continue reading “Meet Tellgen at CACLP 2026 (Booth 3-1504)”

Tellgen Corporation announced its exclusive strategic investment in CytoCares (Shanghai) Inc., marking an important milestone in building an integrated “Diagnosis + Therapy” ecosystem in the field of autoimmune diseases. This collaboration aligns with Tellgen’s long-term strategy to extend its diagnostic expertise into therapeutic innovation and strengthen its capability to provide full-cycle healthcare solutions. Mr. Yao …

Continue reading “Tellgen Announces Strategic Investment in CytoCares to Advance Autoimmune Disease Diagnosis and Therapy”